---

Azathioprine in orbital apex syndrome

---

Case Report

Author Details : Neha Arora, Saptagirish Rambhatla*

Volume : 7, Issue : 3, Year : 2020

Article Page : 210-212

https://doi.org/10.18231/j.ijpp.2020.034

Suggest article by email

Get Permission

---

Abstract

Orbital Apex Syndrome (OAS) is commonly caused by specific inflammations, infections, neoplasms,
iatrogenic, trauma, vascular and non-specific orbital inflammation (NSOI). OAS secondary to NSOI
responds rapidly to corticosteroids. There are very few case reports on azathioprine as additional treatment
modality in OAS secondary to NSOI. We are presenting a 42 years old female who had recurrent episodes
of painful ophthalmoplegia, treated with steroid therapy. Patient was steroid dependant. Therefore, she was
started on azathioprine 2-3mg/kg body weight for 36 weeks. She had complete remission of the painful
ophthalmoplegia, with no further recurrence on 6 months follow-up.

Keywords: Orbital apex Syndrome, Non specific orbital inflammation, Azathioprine.

How to cite : Arora N , Rambhatla S, Azathioprine in orbital apex syndrome. Indian J Pharm Pharmacol 2020;7(3):210-212

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.